Table 4.
Side effect profile
| Side effects | Topiramate group (n=38) | Naltrexone group (n=26) | Acamprosate group (n=28) |
|---|---|---|---|
| Nausea | - | 03 (11.5%) | 07 (25.0%) |
| Vomiting | - | - | - |
| Mild dizziness | 03 (07.9%) | 01 (03.8%) | - |
| Headache | - | 01 (03.8%) | 01 (03.57%) |
| Constipation | - | 02 (07.6%) | - |
| Fatigue | - | 03 (11.4%) | |
| Anxiety | - | 06 (23.07%) | |
| Nervousness | - | 06 (23.07%) | |
| Mild sedation | 05 (13.5%) | - | - |
| Insomnia | - | 04 (15.4%) | - |
| Tingling in skin | 01 (02.6%) | - | 02 (07.14%) |
| Psychomotor | 04 (10.5%) | - | - |
| slowing | |||
| Weight loss | 01 (02.6%) | - | - |
| Clinical signs of | - | - | - |
| organ dysfunction | |||
| Metabolic derangement | - | - | - |
| Diarrhoea | - | - | 06 (21.42%) |
| Pruritus | - | - | 02 (07.14%) |
| Confusion | - | - | - |
| Sexual dysfunction | - | - | 01 (03.57%) |